Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.360
+0.010 (0.43%)
At close: Apr 17, 2026, 4:00 PM EDT
2.368
+0.008 (0.33%)
After-hours: Apr 17, 2026, 5:44 PM EDT

Fortress Biotech Revenue

In the year 2025, Fortress Biotech had annual revenue of $63.26M with 9.69% growth. Fortress Biotech had revenue of $16.08M in the quarter ending December 31, 2025, with 6.34% growth.

Revenue (ttm)
$63.26M
Revenue Growth
+9.69%
P/S Ratio
1.20
Revenue / Employee
$626,356
Employees
78
Market Cap
76.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202563.26M5.59M9.69%
Dec 31, 202457.68M-26.84M-31.76%
Dec 31, 202384.51M8.77M11.58%
Dec 31, 202275.74M6.95M10.11%
Dec 31, 202168.79M23.19M50.86%
Dec 31, 202045.60M8.97M24.49%
Dec 31, 201936.63M9.75M36.26%
Dec 31, 201826.88M9.64M55.88%
Dec 31, 201717.25M11.09M180.09%
Dec 31, 20166.16M5.29M613.44%
Dec 31, 2015863.00K--
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ImmuCell27.64M
Pelthos Therapeutics16.80M
TScan Therapeutics10.33M
Immutep5.28M
Alterity Therapeutics4.43M
NeurAxis3.57M
MediciNova409.66K
Revenue Rankings